Genetic Insights Into Biological Aging And Myasthenia Gravis: A Mendelian Randomization Study Of Telomere Length, Epigenetic Clocks, And Mitochondrial DNA Copy Number
Our bodies age at different rates, and understanding these biological aging processes can offer insights into various diseases. A recent study explored the complex relationship between how our bodies age at a cellular level and an autoimmune disorder called myasthenia gravis. Myasthenia gravis is a condition where the immune system mistakenly attacks healthy tissues, leading to muscle weakness.
The researchers used a method called Mendelian randomization, which leverages genetic variations to determine if there’s a cause-and-effect relationship between different factors, rather than just an association. They looked at three key indicators of biological aging: telomere length, epigenetic clocks, and mitochondrial DNA copy number. Telomeres are protective caps on the ends of our chromosomes that naturally shorten as we age, like the plastic tips on shoelaces. Epigenetic clocks are essentially biological timers that estimate a person’s age based on chemical modifications to their DNA. Finally, mitochondrial DNA copy number refers to the amount of genetic material found in mitochondria, the “powerhouses” of our cells.
The study revealed a fascinating “bidirectional causality” between early-onset myasthenia gravis (a form of the disease that appears at a younger age) and accelerated epigenetic aging. This means that not only does early-onset myasthenia gravis contribute to faster biological aging at the epigenetic level, but this accelerated aging also plays a role in the progression of the disease, creating a self-reinforcing cycle. Additionally, the findings suggest a potential connection between the number of mitochondrial DNA copies and late-onset myasthenia gravis (which develops later in life). This could indicate a compensatory mechanism in the body to deal with chronic oxidative stress, a type of cellular damage, in age-related autoimmune conditions.
These insights highlight that biological aging is intricately linked to myasthenia gravis, with different aging markers playing distinct roles depending on when the disease begins. This deeper understanding could pave the way for more targeted treatments for this challenging condition.
Source: link to paper